Black & White Peptides Ltd. Registered in England & Wales, company number 16876162.
Research Handling Guide
Reference material on the peptide and small-molecule research compounds we supply – what they are, how to reconstitute and store them in the laboratory, and how to calculate concentrations. All compounds are supplied for in-vitro laboratory research only, not for human consumption.
1. What Are Research Peptides?
Peptides are short chains of amino acids linked by peptide bonds. Where proteins typically contain hundreds or thousands of residues, peptides are usually between two and fifty. Many of the research compounds we supply are synthetic analogues of endogenous peptides or fragments thereof, produced to defined sequences for use in laboratory experiments.
In a research setting, synthetic peptides are used as reference standards, ligands for receptor binding studies, and probes for investigating cell-signalling pathways in cultured cells and other in-vitro models. The compounds we supply are research reagents only; they are not pharmaceutical products and are not intended for human or veterinary use.
2. How Peptides Are Studied in the Literature
Peptides are typically characterised in the research literature by the receptor or biochemical pathway they interact with. Examples of how several compound classes are described in peer-reviewed studies:
- GLP-1 / GIP receptor agonists (Tirzepatide, Semaglutide, Liraglutide) – characterised as agonists at incretin receptors in preclinical metabolic models.
- Growth-hormone-releasing-hormone analogues & ghrelin-receptor agonists (HGH, Sermorelin, CJC 1295, Ipamorelin, GHRP-2/6, Tesamorelin, IGF-1 LR3) – characterised as growth-hormone secretagogues in preclinical studies of pituitary signalling.
- Melanocortin-receptor agonists (MT-1, Melanotan 2, PT-141) – characterised as α-MSH analogues in receptor-binding studies.
- Regenerative peptides (BPC-157, TB-500, Thymosin Alpha-1, ARA290) – studied in preclinical models of connective-tissue, gastrointestinal and immune-cell signalling.
- Neuropeptides (Semax, Selank, Oxytocin, Kisspeptin-10, DSIP) – studied in central-nervous-system and circadian signalling research.
These descriptions summarise how the compounds are characterised in the published scientific literature. They are not claims about effects in humans.
3. Research Areas We Cover
Metabolic Research
Incretin-receptor agonists (GLP-1, GIP, glucagon, amylin) and small-molecule AMPK / NNMT compounds studied in metabolic-signalling research.
Tirzepatide, Semaglutide, Liraglutide, Cagrilintide, AOD9604, 5-Amino-1MQ, AICAR
GHRH / Secretagogue Research
GHRH analogues and ghrelin-receptor agonists characterised as growth-hormone secretagogues in preclinical literature.
HGH, Sermorelin, CJC 1295 (with / without DAC), GHRP-2, GHRP-6, Ipamorelin, Tesamorelin, IGF-1 LR3
Regenerative Research
Peptides studied in preclinical tissue, gastrointestinal, and immune-cell research models.
BPC-157, TB-500, KLOW Blend, Thymosin Alpha-1, ARA290
Longevity Research
Endogenous and synthetic compounds studied in cellular-energetics, redox, and mitochondrial research.
GHK-Cu, NAD+, Epithalon, MOTS-c, Glutathione
Neuropeptide Research
Synthetic and endogenous neuropeptides studied at central-nervous-system and circadian signalling targets.
Semax, Selank, Adamax, Kisspeptin-10, Oxytocin, DSIP, Melatonin
Melanocortin Research
α-MSH analogues characterised as melanocortin-receptor agonists in receptor-binding studies.
MT-1, Melanotan 2 (MT-2), PT-141 (Bremelanotide)
4. Laboratory Reconstitution Procedure
Most peptides are supplied as a lyophilised (freeze-dried) powder in a sealed vial. Before use as a laboratory reagent, they are typically reconstituted in a suitable aqueous diluent – bacteriostatic water is the most common reference diluent cited in the research literature.
Clean the vial
Wipe the septum of the peptide vial and the diluent vial with an alcohol swab before penetrating.
Draw diluent
Using a clean syringe, draw the volume of diluent required to reach your target concentration.
Add slowly
Insert the needle into the peptide vial and release the diluent slowly down the side wall. Do not spray directly onto the lyophilised powder as this can cause foaming and loss of material.
Dissolve gently
Swirl the vial gently until the powder is fully in solution. Do not vortex or shake – mechanical agitation can denature the peptide.
Refrigerate
Store the reconstituted solution at 2–8 °C. Shelf life after reconstitution varies by compound; consult the relevant literature for the peptide in question.
5. Concentration Calculations
Once a lyophilised compound has been dissolved in a known volume of diluent, the resulting concentration is calculated as:
Concentration (mg/ml) = mass of compound (mg) ÷ volume of diluent (ml)
Or, expressed in micrograms per millilitre:
Concentration (µg/ml) = mg/ml × 1000
Worked example: 10 mg of lyophilised peptide dissolved in 2 ml of bacteriostatic water gives a concentration of 5 mg/ml, or 5000 µg/ml.
These calculations are provided for laboratory reference only. They are not, and are not intended to be, dosing guidance for human or veterinary use.
6. Storage & Handling
| State | Temperature | Typical shelf life |
|---|---|---|
| Lyophilised (unreconstituted) | 2–8 °C (refrigerated) or −20 °C (frozen) | Up to 24 months, compound-dependent |
| Reconstituted (in solution) | 2–8 °C (refrigerated) | Typically 4–6 weeks, compound-dependent |
| Short-term transport | Below 25 °C | Up to 90 days for most lyophilised peptides |
- Keep away from direct sunlight and heat sources.
- Avoid freeze-thaw cycles on reconstituted solutions.
- Reference diluent in the literature is typically bacteriostatic water (0.9% benzyl alcohol) for multi-use vials or sterile water for single-use solutions.
- Use a fresh sterile needle each time the vial septum is penetrated.
7. Vials vs Pens Format
We supply most compounds in two formats: traditional lyophilised vials, and pre-reconstituted multi-dose pen cartridges. The choice depends on the research workflow.
Vials (lyophilised)
- Longer shelf life in lyophilised form
- Requires laboratory reconstitution step
- Flexible concentration by choice of diluent volume
- Lower cost per mg
- Requires syringes and compatible diluent
Pens (pre-reconstituted)
- Pre-filled multi-dose cartridge
- No reconstitution step required
- Fixed mg/ml concentration set at manufacture
- Convenient for repeated bench work
- Shorter shelf life than lyophilised format
8. Purity & Third-Party Testing
Purity matters in research. The peptides we supply are independently verified by Janoshik Analytical using high-performance liquid chromatography (HPLC) and mass spectrometry. Lab reports include the batch identifier, purity percentage, and the Janoshik verification key so results can be authenticated against Janoshik’s records.
Third-party testing is the most reliable way to confirm that a research reagent matches its stated specification. We publish the verification records on our Purity page and supply the printed Janoshik report with the order where one has been issued for the current batch.
9. Laboratory Best Practices
- Use third-party tested compounds – all reagents we supply are HPLC-verified by Janoshik Analytical.
- Use an appropriate diluent – typically bacteriostatic water or a specified buffer, per the literature for that compound.
- Maintain sterile technique – swab septa, use fresh needles, and avoid cross-contamination between vials.
- Keep a lab notebook – record batch identifiers, reconstitution dates, diluent volumes, and storage history.
- Observe the compliance statement – all products sold by Black & White Peptides Ltd are supplied for laboratory research and in-vitro use only. They are not pharmaceuticals and are not for human or veterinary consumption.
